FATE

FATE THERAPEUTICS INC

Healthcare · Biotechnology

$191.20 sample

-2.48 (-1.28%) 1D

Market cap

$351.0B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-30

Alerts

8

Price$191.20 +10.38% 3M daily closessample

196.99173.22

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30SEC10-Q filed
Sep 24INSInsider buy: Chief Financial Officer
Sep 21INSInsider sell: General Counsel
Sep 16INSInsider sell: Director
Sep 07INSInsider buy: Chief Financial Officer
Sep 01INSInsider buy: Chief Financial Officer
Aug 24INSInsider sell: Chief Financial Officer
Aug 17INSInsider buy: Chief Financial Officer

Sign up to see the real FATE record →

Company facts

SEC EDGAR registration

Name: FATE THERAPEUTICS INC
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -34sample, -100 to +100
Reporting currency: USD

Who is positioning in FATE

sample

Insiders: 16 insider transactions over 90 days, net selling, $482.2M
Congress: 2 members traded over 90 days
Institutions · 13F: 41 funds hold $3.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$19.7B +18.3% y/y

Q4 2024Q3 2026

Inventory$12.3B +15.9% y/y

Q4 2024Q3 2026

Accounts receivable$8.6B +13.7% y/y

Q4 2024Q3 2026

Total debt$23.8B +8.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $229.8B +3.7% 3M
Sample peer B: $94.4B -5.8% 3M
Sample peer C: $229.5B +16.2% 3M
Sample peer D: $342.1B +7.2% 3M
Sample peer E: $51.2B -6.4% 3M